Protective effects of captopril against ischemic stress: Role of cellular Mg

Hypertension

Volumn 34, Issue 4 II, 1999, Pages 958-963

  Barbagallo, Mario ^b   Dominguez, Ligia J ^c   Resnick, Lawrence M ^a  

^a WAYNE STATE UNIVERSITY   (United States)

^b UNIVERSITY OF PALERMO   (Italy)

^c NONE

Author keywords

Captopril; Ischemia; Magnesium; Red blood cells; Spectroscopy, magnetic resonance; Sulfhydryls

Indexed keywords

2,3 DIPHOSPHOGLYCERIC ACID; ADENOSINE TRIPHOSPHATE; CAPTOPRIL; MAGNESIUM; PHOSPHATE;

ARTICLE; CELL PROTECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ERYTHROCYTE; FEMALE; HUMAN; HUMAN CELL; ISCHEMIA; MALE; MODEL; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL;

EID: 0032736184     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.34.4.958     Document Type: Article

References (34)

1. Misik V, Mak IT, Stafford RE, Weglicki WB. Reactions of captopril and epicaptopril with transition metal ions and hydroxyl radicals: an EPR spectroscopy study. Free Radic Biol Med. 1993;15:611-619.
2. Bagchi D, Prasad R, Das DK. Direct scavenging of free radicals by captopril, an angiotensin converting enzyme inhibitor. Biochem Biophys Res Commun. 1989;158:52-57.
3. Mak IT, Freedman AM, Dickens BF, Weglicky WB. Protective effect of sulfhydryl-containing angiotensin converting enzyme inhibitors against free radicals injury in endothelial cells. Biochem Pharmacol. 1990;40: 2169-2175.
4. Van Gilst WH, De Graef PA, Wesseling H, De Langen C. Reduction of reperfusion arrhythmias in the ischemic isolated rat heart by angiotensin converting enzyme inhibitors: a comparison of captopril, enalapril and HOE 498. J Cardiovasc Pharmacol. 1986;8:722-728.
5. Flaherty JT, Weisfeldt ML. Reperfusion injury. Free Radic Biol Med. 1988;5:409-419.
6. Turlapaty PDVM, Altura BM. Magnesium deficiency produces spasms of coronary arteries: Relationship to etiology of sudden death ischemic heart disease. Science. 1980;208:198-200.
7. 31P-NMR study. Biochim Biophys Acta. 1993; 1182:329-332.
8. Wu F, Zou L, Altura BT, Barbour RL, Altura BM. Low extracellular magnesium results in cardiac failure in isolated perfused rat hearts. Magn Trace Elem. 1991;10:364-373.
9. Bloom S. Magnesium deficiency cardiomyopathies. Am J Cardiovasc Pathol. 1988;2:7-17.
10. Borchgrevink PC, Oksendal AN, Jynge P. Acute extracellular magnesium deficiency and myocardial tolerance to ischemia. J Am Coll Nutr. 1987; 6:125-130.
11. Freedman AM, Mak IT, Cassidy MM, Weglicky WB. Magnesium deficient red blood cells exhibit an enhanced sensitivity to oxidative stress. Free Radic Biol Med. 1990;9:119.
12. Freedman AM, Cassidy MM, Weglicky WB. Captopril protects against myocardial injury induced by magnesium deficiency. Hypertension. 1991;18:142-147.
13. Barbagallo M, Dominguez LJ, Tagliamonte MR, Resnick LM, Paolisso G. Effects of glutathione on red blood cell intracellular magnesium: relation to glucose metabolism. Hypertension. 1999;34:76-82.
14. Duchin KL, McKinstry DN, Cohen AI, Migfalof BH. Pharmacokinetics of captopril in healthy subjects and in patients with cardiovascular diseases. Clin Pharmacokinetics. 1988;14:241-259.
15. Resnick LM, Gupta RK, Laragh JH. Intracellular free magnesium in erythrocytes of essential hypertension. Proc Natl Acad Sci (U S A). 1984; 81:6511-6515.
16. Resnick L, Gupta R, Bhargava K, Gruenspan H, Alderman M, Laragh J. Cellular ions in hypertension, diabetes, and obesity: a nuclear magnetic resonance spectroscopic study. Hypertension. 1991;17:951-957.
17. Resnick LM. Ionic basis of hypertension, insulin resistance, vascular disease, and related disorders: mechanism of syndrome X. Am J Hyper. 1993;6:123s-134s.
18. Barbagallo M, Dominguez LJ, Putignano E, Barbagallo-Sangiorgi G, Resnick LM. Effect of aging on intracellular divalent cation metabolism: a link to the increased incidence of hypertension and non-insulin dependent diabetes mellitus in the elderly? Arch Gerontol. 1996;(suppl 5):233-238.
19. Cross CE, Halliwell B, Borisch ET, Pryor WA, Ames BN, Saul RL, McCord JM, Harman D. Oxygen radicals and human diseases. Ann Intern Med. 1987;107:526-545.
20. Rayssiguier Y, Durlach J, Gueux E, Rock E, Mazur A. Magnesium and ageing: experimental data: importance of oxidative damage. Magn Res. 1993;6:369-378.
21. Kramer JH, Misik V, Weglicky WB. Magnesium deficiency potentiates free radical production associated with post-ischemic injury to rat hearts: vitamin E affords protection. Free Radic Biol Med. 1994; 16:713-723.
22. Weglicki WB, Bloom S, Cassidy MM, Freedman AM, Atrakchi AH, Dickens BF, Mak IT. Antioxidant and the cardiomyopathy of Mg-deficiency. Am J Cardiovasc Pathol. 1992;4:210-215.
23. Wu F, Altura BT, Gao J, Barbour RL, Altura BM. Ferrylmyoglobin formation induced by acute magnesium deficiency in perfused rat heart causes cardiac failure. Biochim Biophys Acta. 1994;1225:158-164.
24. Freedman AM, Mak IT, Stafford RE, Dickens BF, Cassidy MM, Muesing RA, Weglicki WB. Erythrocytes from magnesium-deficient hamsters display an enhanced susceptibility to oxidative stress. Am J Physiol. 1992;262:C1371-C1375.
25. Afanas'ev IB, Suslova TB, Cheremisina ZP, Abramova NE, Korkina LG. Study of antioxidant properties of metal aspartates. Analyst. 1995;120: 859-862.
26. De Leeuw I, Engelen W, Aerts P, Schrans S. Effect of intensive magnesium supplementation on the in vitro oxidizability of LDL and VLDL in Mg-depleted type 1 diabetic patients. Magnes Res. 1998;11: 179-182.
27. Garcia LA, Dejong SC, Martin SM, Smith RS, Buettner GR, Kerber RE. Magnesium reduces free radicals in an in vivo coronary occlusion-reperfusion model. J Am Coll Cardiol. 1998;32:536-539.
28. Kilgore KS, Homeister JW, Satoh PS, Lucchesi ITLE. Sulfhydryl compounds, captopril, and MPG inhibit complement-mediated myocardial injury. Am J Physiol. 1994;266:H28-H35.
29. Przyklenk K, Kloner RA. Cardioprotection by ACE-inhibitors in acute ischemia and infarction. Basic Res Cardiol. 1993;88:139-154.
30. Altura BM, Altura BT. Magnesium and cardiovascular biology: an important link between cardiovascular risk factors and atherogenesis. Cell Mol Biol Res. 1995;41:347-359.
31. 2+ modulates membrane lipids in vascular smooth muscle: a link to atherogenesis. FEBS Lett. 1997;408:191-194.
32. Bartosz M, Kedziora J, Bartosz G. Antioxidant and prooxidant properties of captopril and enalapril. Free Radic Biol Med. 1997;23:729-735.
33. Zhang A, Cheng TP, Altura BM. Magnesium regulates intracellular free ionized calcium concentration and cell geometry in vascular smooth muscle cells. Biochim Biophys Acta. 1992;1134:25-29.
34. 2+: relevance to sudden infant death syndrome. Eur J Pharm. 1997;338:R7-R9.